{"name":"Adapt Produtos Oftalmológicos Ltda.","slug":"adapt-produtos-oftalmol-gicos-ltda","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"moxifloxacin 0,5% + prednisolone 1%","genericName":"moxifloxacin 0,5% + prednisolone 1%","slug":"moxifloxacin-0-5-prednisolone-1","indication":"Bacterial conjunctivitis, keratitis, and blepharitis","status":"phase_3"},{"name":"moxifloxacin/prednisolone combination","genericName":"moxifloxacin/prednisolone combination","slug":"moxifloxacin-prednisolone-combination","indication":"Bacterial conjunctivitis","status":"phase_3"}]}],"pipeline":[{"name":"moxifloxacin 0,5% + prednisolone 1%","genericName":"moxifloxacin 0,5% + prednisolone 1%","slug":"moxifloxacin-0-5-prednisolone-1","phase":"phase_3","mechanism":"Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, while prednisolone is a corticosteroid that reduces inflammation by inhibiting phospholipase A2 and other pro-inflammatory enzymes.","indications":["Bacterial conjunctivitis, keratitis, and blepharitis"],"catalyst":""},{"name":"moxifloxacin/prednisolone combination","genericName":"moxifloxacin/prednisolone combination","slug":"moxifloxacin-prednisolone-combination","phase":"phase_3","mechanism":"Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, while prednisolone is a corticosteroid that reduces inflammation by inhibiting phospholipase A2 and other enzymes.","indications":["Bacterial conjunctivitis","Uveitis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}